Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis
The Lancet,

Forouzanfar MH et al. – Breast and cervical cancer are important causes of mortality in women aged ≥15 years. We undertook annual age-specific assessments of breast and cervical cancer in 187 countries.


  • Systematically collected cancer registry data on mortality and incidence, vital registration, and verbal autopsy data for the period 1980—2010
  • Modelled the mortality-to-incidence (MI) ratio using a hierarchical model
  • Vital registration and verbal autopsy were supplemented with incidence multiplied by the MI ratio to yield a comprehensive database of mortality rates
  • Used Gaussian process regression to develop estimates of mortality with uncertainty by age, sex, country, and year
  • Used out-of-sample predictive validity to select the final model
  • Estimates of incidence with uncertainty were also generated with mortality and MI ratios

  • Global breast cancer incidence increased from 641 000 (95% uncertainty intervals 610 000—750 000) cases in 1980 to 1 643 000 (1 421 000—1 782 000) cases in 2010, an annual rate of increase of 3·1%
  • Global cervical cancer incidence increased from 378 000 (256 000—489 000) cases per year in 1980 to 454 000 (318 000—620 000) cases per year in 2010—a 0·6% annual rate of increase
  • Breast cancer killed 425 000 (359 000—453 000) women in 2010, of whom 68 000 (62 000—74 000) were aged 15—49 years in developing countries
  • Cervical cancer death rates have been decreasing but the disease still killed 200 000 (139 000—276 000) women in 2010, of whom 46 000 (33 000—64 000) were aged 15—49 years in developing countries
  • Recorded pronounced variation in trend in breast cancer mortality across regions and countries

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Anti-angiogenic therapy versus dose-dense paclitaxel therapy for frontline treatment of epithelial ovarian cancer: Review of phase III randomized clinical trials Current Oncology Reports, October 24, 2014    Review Article

2 Egg consumption is associated with increased risk of ovarian cancer: Evidence from a meta-analysis of observational studies Clinical Nutrition, October 28, 2014    Evidence Based Medicine    Review Article

3 Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: A randomised phase 2 study The Lancet Oncology, October 2, 2014    Clinical Article

4 Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium International Journal of Cancer, October 3, 2014    Clinical Article

5 Surgical results of pelvic exenteration in the treatment of gynecologic cancer Full Text World Journal of Surgical Oncology, September 29, 2014    Free full text    Clinical Article

6 Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer International Journal of Gynecological Cancer, October 13, 2014    Clinical Article

7 Pathologic findings at risk-reducing salpingo-oophorectomy: Primary Results From Gynecologic Oncology Group Trial GOG-0199 Journal of Clinical Oncology, September 22, 2014    Clinical Article

8 Adult granulosa cell tumours of the ovary Current Opinion in Oncology, August 15, 2014    Review Article

9 High-grade undifferentiated sarcomas of the uterus: Diagnosis, outcomes, and new treatment approaches Current Oncology Reports, September 4, 2014    Clinical Article

10 Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: Safety and two-year efficacy results from a multicentre, single-arm, phase II study British Journal of Cancer, October 6, 2014    Clinical Article

11 Complications and long-term follow-up on colorectal resections in the treatment of deep infiltrating endometriosis extending to bowel wall Acta Obstetricia et Gynecologica Scandinavica, October 6, 2014    Review Article

12 End-of-life care for older patients with ovarian cancer is intensive despite high rates of hospice use Journal of Clinical Oncology, October 13, 2014    Clinical Article

13 Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian Cancer, October 3, 2014    Review Article

14 Menstrual pain and epithelial ovarian cancer risk Cancer Causes and Control, September 16, 2014    Clinical Article

15 Human papillomavirus and host genetic polymorphisms in carcinogenesis: A systematic review and meta-analysis Journal of Clinical Virology, August 13, 2014    Evidence Based Medicine    Review Article

16 Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas Acta Obstetricia et Gynecologica Scandinavica, October 20, 2014    Clinical Article

17 Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary International Journal of Gynecological Cancer, September 4, 2014    Evidence Based Medicine

18 Effect of ultrasound sonication on clonogenic survival and mitochondria of ovarian cancer cells in the presence of methylene blue Journal of Ultrasound in Medicine, October 6, 2014    Clinical Article

19 Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): A multicentre, open-label, randomised, phase 2 trial The Lancet Oncology, October 14, 2014    Clinical Article

20 Anthropometric factors and ovarian cancer risk: A systematic review and nonlinear dose-response meta-analysis of prospective studies International Journal of Cancer, October 3, 2014    Evidence Based Medicine    Review Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore